A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences 22.19 (2021): 10227.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Bosch, Naomi C.
Martin, Lena-Marie
Voskens, Caroline J.
Berking, Carola
Seliger, Barbara
Schuler, Gerold
Schaft, Niels
Dörrie, Jan
- DOI
-
10.3390/ijms221910227
- URN
-
urn:nbn:de:bvb:29-opus4-195174
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bosch, Naomi C.
- Martin, Lena-Marie
- Voskens, Caroline J.
- Berking, Carola
- Seliger, Barbara
- Schuler, Gerold
- Schaft, Niels
- Dörrie, Jan
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
Engineering designer dendritic cells to activate natural killer cells
Chimeric toxins for specific targeting of cancer cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
CX3CR1+ antigen presenting cells of the lamina propria activate CD4 T cells during transfer colitis
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
NFK
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
Engineering designer dendritic cells to activate natural killer cells
Chimeric toxins for specific targeting of cancer cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
CX3CR1+ antigen presenting cells of the lamina propria activate CD4 T cells during transfer colitis
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
NFK
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
Engineering designer dendritic cells to activate natural killer cells
Chimeric toxins for specific targeting of cancer cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
CX3CR1+ antigen presenting cells of the lamina propria activate CD4 T cells during transfer colitis
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
NFK